These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23777766)

  • 1. Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.
    Ren M; Qin H; Kitamura E; Cowell JK
    Blood; 2013 Aug; 122(6):1007-16. PubMed ID: 23777766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.
    Ren M; Qin H; Wu Q; Savage NM; George TI; Cowell JK
    Int J Cancer; 2016 Aug; 139(4):836-40. PubMed ID: 27005999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML.
    Cai B; Liu Y; Chong Y; Mori SF; Matsunaga A; Zhang H; Fang X; Chang CS; Cowell JK; Hu T
    Mol Cancer; 2022 Jul; 21(1):156. PubMed ID: 35906694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
    Ren M; Cowell JK
    Blood; 2011 Jun; 117(25):6837-47. PubMed ID: 21527531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.
    Ren M; Qin H; Ren R; Tidwell J; Cowell JK
    Cancer Res; 2011 Dec; 71(23):7312-22. PubMed ID: 21937681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.
    Ren M; Li X; Cowell JK
    Blood; 2009 Aug; 114(8):1576-84. PubMed ID: 19506298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.
    Qin H; Wu Q; Cowell JK; Ren M
    Haematologica; 2016 Mar; 101(3):e91-4. PubMed ID: 26589915
    [No Abstract]   [Full Text] [Related]  

  • 9. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
    Agerstam H; Järås M; Andersson A; Johnels P; Hansen N; Lassen C; Rissler M; Gisselsson D; Olofsson T; Richter J; Fan X; Ehinger M; Fioretos T
    Blood; 2010 Sep; 116(12):2103-11. PubMed ID: 20554971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies.
    Cai B; Liu Y; Chong Y; Zhang H; Matsunaga A; Fang X; Pacholczyk R; Zhou G; Cowell JK; Hu T
    Mol Cancer; 2021 Dec; 20(1):165. PubMed ID: 34906138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
    Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
    Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
    Kumar KR; Chen W; Koduru PR; Luu HS
    Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct signaling programs associated with progression of FGFR1 driven leukemia in a mouse model of stem cell leukemia lymphoma syndrome.
    Silva J; Chang CS; Hu T; Qin H; Kitamura E; Hawthorn L; Ren M; Cowell JK
    Genomics; 2019 Dec; 111(6):1566-1573. PubMed ID: 30439482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
    Duckworth CB; Zhang L; Li S
    Int J Clin Exp Pathol; 2014; 7(2):801-7. PubMed ID: 24551307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage.
    Ren M; Tidwell JA; Sharma S; Cowell JK
    PLoS One; 2012; 7(6):e38265. PubMed ID: 22701616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
    Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
    Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a patient].
    Chao H; Chen S; Zhou M; Lu X; Zhang X; Pan J; Wu C; Zhang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):679-82. PubMed ID: 26418991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities.
    Ren M; Qin H; Ren R; Cowell JK
    Leukemia; 2013 Jan; 27(1):32-40. PubMed ID: 22781593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
    Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
    Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
    [No Abstract]   [Full Text] [Related]  

  • 20. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
    Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
    Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.